Skip to main content
Glama

Biosamples

by io.github.pipeworx-io

Entity Profile

entity_profile
Read-onlyIdempotent

"Tell me about X" / "research Acme" / "brief me on Tesla" / "what does Apple do" / "company profile for Microsoft" / "give me the rundown on NVDA" / "everything you know about $TICKER" — full cross-source profile of a US public company in ONE parallel call. ALWAYS PREFER over chaining single-pack SEC/XBRL/news lookups when the user asks for a holistic view. Fans out across SEC EDGAR, XBRL, USPTO patents, federal contracts (USAspending), FDA-licensed biologics (Purple Book), H-1B hiring (DOL LCA), news and GLEIF, and returns: cik + company_name (+ resolved_from/resolved_to when value was a name); recent_filings (up to 5 with pipeworx://edgar/company/{cik}/filings/{accession} URIs); fundamentals (LATEST 10-K Revenues + NetIncomeLoss + Cash, sorted period_end DESC); patents (USPTO PatentsView API sunset May 2025 — soft-fails until reactivated); federal_contracts (USAspending awards where the company is the recipient); fda_products (FDA-licensed biologics — vaccines, cell/gene therapies — from the Purple Book; a company with only small-molecule/generic drugs will show none here, that is expected, not a failure); hiring (H-1B sponsorship volume + salary range from DOL LCA filings); recent news mentions via GDELT→GNews fallback; LEI via GLEIF. sources_used / sources_failed say which of these actually returned data for THIS company — an empty section is a real "no data", not a bug. Pass a ticker ("AAPL"), zero-padded CIK ("0000320193"), OR a company name ("Moderna") — names now resolve via SEC EDGAR's company-name match; a private company (no CIK/ticker) returns resolved:false with an explicit notes line, not a bare failure. type accepts "company" or "ticker" interchangeably — both take the same value shapes above.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYes"company" or "ticker" — both are accepted and behave identically; `value` can be a ticker, CIK, or company name either way. person/place coming soon.
valueYesTicker (e.g., "AAPL"), zero-padded CIK (e.g., "0000320193"), or company name (e.g., "Moderna") — names resolve via SEC EDGAR company-name match.

TDQS

A4.9/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already indicate readOnly, openWorld, idempotent, non-destructive. The description adds valuable behavioral context: it fans out across multiple sources in parallel, soft-fails for patents (May 2025 sunset), and provides specific return fields. No contradiction with annotations.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is somewhat verbose but well-structured, with front-loaded example queries and a clear list of return fields. Every sentence adds value, though it could be slightly tighter. Still, it is efficient given the complexity.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Given the tool's complexity (multi-source, no output schema), the description is very complete. It covers return fields, source details, limitations (patents sunset, name handling), and example inputs. The agent has sufficient context to invoke the tool correctly.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100%, and the description enriches parameter meaning significantly. It clarifies that 'value' accepts ticker or zero-padded CIK but not names, and that 'type' only supports 'company' for now. This adds practical guidance beyond the schema.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly states the tool provides a full cross-source profile of US public companies in one parallel call, listing specific sources and return fields. It distinguishes from siblings by explicitly recommending this tool over chaining single-pack lookups and referencing related tools like compare_entities and resolve_entity.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description gives explicit example queries for when to use the tool and advises to prefer it over chaining separate lookups. It also specifies limitations: names not supported, use resolve_entity first, and notes the patents API sunset. This provides clear when-to-use and when-not-to-use guidance.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

All Biosamples toolsInspect
Try in Browser
RayrunBuild, deploy, and operate MCP servers without becoming an infrastructure team.ray.runAd

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.8/5.0
Disambiguation2/5

Many tools overlap heavily: ask_pipeworx, ask_pipeworx_beta, and ask_pipeworx_grounded are near-identical variants (beta currently identical), and the set includes five-plus prediction-market tools (polymarket_arbitrage, polymarket_edges, polymarket_edge_tracker, polymarket_fill_risk, polymarket_kalshi_spread, bet_research) with fuzzy boundaries. Long descriptions help, but an agent selecting among them would frequently struggle to pick the right one.

Naming Consistency3/5

Names are uniformly lowercase snake_case, but the pattern is inconsistent: verb_first names (search_samples, validate_claim, resolve_entity) mix with noun-style names (entity_profile, pipeworx_trending, polymarket_arbitrage) and bare imperatives (remember, recall, forget, subscribe). It is readable, but there is no predictable verb_noun convention across the set.

Tool Count2/5

33 tools is well over the coherent range, and the count is especially inflated because the server is named Biosamples yet only two tools (search_samples, get_sample) actually belong to that domain. The remaining 31 tools are an unrelated mix of Pipeworx research, prediction-market, memory, and subscription utilities, including redundant variants.

Completeness2/5

For the stated Biosamples purpose, only search and retrieve exist—no submission, update, or batch operations—so the domain surface is a read-only fragment. For the broader accidental scope of the other tools, the set is a grab bag with no coherent lifecycle, leaving significant gaps regardless of which domain is considered primary.

Resources